Provided by Tiger Trade Technology Pte. Ltd.

Brainsway Ltd.

23.90
-2.1400-8.22%
Post-market: 23.900.00000.00%16:10 EST
Volume:97.86K
Turnover:2.39M
Market Cap:467.89M
PE:93.45
High:25.44
Open:25.25
Low:23.56
Close:26.04
52wk High:26.63
52wk Low:7.84
Shares:19.58M
Float Shares:12.09M
Volume Ratio:0.97
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2558
EPS(LYR):0.1107
ROE:10.95%
ROA:1.92%
PB:6.68
PE(LYR):215.84

Loading ...

Press Release: BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.

Dow Jones
·
Yesterday

Brainsway says Cigna’s Evernorth to eliminate authorization requirement for TMS

TIPRANKS
·
Feb 18

Analysts Are Bullish on Top Healthcare Stocks: ImmunityBio (IBRX), Brainsway (BWAY)

TIPRANKS
·
Jan 26

Brainsway price target raised to $30 from $24 at H.C. Wainwright

TIPRANKS
·
Jan 26

Brainsway price target raised to $30 from $23 at Northland

TIPRANKS
·
Jan 22

Brainsway announces U.S. FDA granted PMA for Neurolief’s ProlivRx system

TIPRANKS
·
Jan 12

Brainsway Says Premera Blue Cross Blue Shield Expands Coverage to Include Depression Treatment

MT Newswires Live
·
Jan 07

Brainsway Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 08, 2025

Brainsway Ltd : H.c. Wainwright Raises Target Price to $24 From $18

THOMSON REUTERS
·
Dec 08, 2025

BrainsWay Begins Clinical Trial of Deep TMS 360 System in Alcohol Use Disorder

MT Newswires Live
·
Nov 17, 2025

Brainsway price target raised to $18 from $17 at H.C. Wainwright

TIPRANKS
·
Nov 13, 2025

BrainsWay Receives FDA Clearance for Adolescent Depression Treatment

MT Newswires Live
·
Nov 13, 2025

Brainsway’s Deep TMS device granted FDA clearance in Major Depressive Disorder

TIPRANKS
·
Nov 13, 2025

Brainsway Is Maintained at Outperform by Northland Capital Markets

Dow Jones
·
Nov 13, 2025

Brainsway Ltd : Northland Capital Raises Target Price to $23 From $19

THOMSON REUTERS
·
Nov 12, 2025

BrainsWay Q3 EPS $0.04 Misses $0.07 Estimate, Sales $13.512M Beat $13.041M Estimate

Benzinga
·
Nov 11, 2025

Press Release: BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights

Dow Jones
·
Nov 11, 2025

Brainsway Ltd expected to post earnings of 6 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

Northland Securities Sticks to Their Buy Rating for Brainsway (BWAY)

TIPRANKS
·
Sep 17, 2025

Brainsway Says US FDA Approves Accelerated Protocol for Major Depression Treatment System

MT Newswires Live
·
Sep 16, 2025